Skip to main content

Jennifer Anne Rymer

Associate Professor of Medicine
Medicine, Cardiology

Current Appointments & Affiliations


Associate Professor of Medicine · 2024 - Present Medicine, Cardiology, Medicine

In the News


Published September 18, 2025
Daylight Saving Time May Not Trigger Heart Attacks After All, Study Finds
Published August 2, 2021
The Heart of Inclusion: How Cardiology Responded to a Wake-up Call on Diversity

View All News

Recent Publications


Association of Race and Ethnicity With High-Potency P2Y12 Inhibitors Prescription Among Patients With Acute MI Undergoing PCI: An Analysis From the CathPCI Registry.

Journal Article Circ Cardiovasc Interv · January 2, 2026 BACKGROUND: Racial and ethnic disparities exist in postacute myocardial infarction (AMI) care. High-potency P2Y12 inhibitors use among patients with AMI who undergo percutaneous coronary intervention (PCI) carries a class I indication in the guidelines. Th ... Full text Link to item Cite

The impact of intravascular imaging on percutaneous coronary intervention outcomes in acute myocardial infarction: a systematic review and meta-analysis.

Journal Article Coron Artery Dis · December 1, 2025 BACKGROUND: Intravascular imaging (IVI) facilitates optimal outcomes in percutaneous coronary intervention (PCI). Focused data on the impact of IVI on outcomes of PCI in acute myocardial infarction (AMI), in particular, are scarce. METHODS: A systematic se ... Full text Link to item Cite

Optimal Management of Bifurcation Coronary Disease: Current Evidence and Future Directions

Journal Article Current Treatment Options in Cardiovascular Medicine · December 1, 2025 Purpose of Review: To explore the cumulative evidence of various strategies to percutaneously manage bifurcation coronary artery disease including procedural planning, technical considerations and secondary prevention therapies. Recent Findings: Numerous c ... Full text Cite
View All Publications

Recent Grants


1/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2025 - 2029

Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk: A randomized trial

Clinical TrialPrincipal Investigator · Awarded by DCRI-Duke-Site · 2025 - 2029

Patient Advisory Board and Faculty Effort across multiple studies

Clinical TrialPrincipal Investigator · Awarded by Abiomed · 2023 - 2028

View All Grants

Education, Training & Certifications


Vanderbilt University, School of Medicine · 2011 M.D.